HC Wainwright & Co. analyst Edward White downgrades Vyant Bio (NASDAQ:VYNT) from Buy to Neutral.
Rosenblatt Initiates Coverage On Stagwell with Buy Rating, Announces Price Target of $10
Rosenblatt analyst Barton Crockett initiates coverage on Stagwell (NASDAQ:STGW) with a Buy rating and announces Price Target of $10.